CoChat

Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery

Open access
Feric, Nicole T, Pallotta, Isabella, Singh, Rishabh, Bogdanowicz, Danielle R, Gustilo, Marietta M, Chaudhary, Khuram W, Willette, Robert N, Chendrimada, Tim P, Xu, Xiaoping, Graziano, Michael P, Aschar-Sobbi, Roozbeh · 2019 · Toxicological Sciences
Cited by 96

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Recent advances in techniques to differentiate human induced pluripotent stem cells (hiPSCs) hold the promise of an unlimited supply of human derived cardiac cells from both healthy and disease populations. That promise has been tempered by the observation that hiPSC-derived cardiomyocytes (hiPSC-CMs) typically retain a fetal-like phenotype, raising concern about the translatability of the in vitro data obtained to drug safety, discovery, and development studies. The Biowire II platform was used to generate 3D engineered cardiac tissues (ECTs) from hiPSC-CMs and cardiac fibroblasts. Long term electrical stimulation was employed to obtain ECTs that possess a phenotype like that of adult human myocardium including a lack of spontaneous beating, the presence of a positive force-frequency response from 1 to 4 Hz and prominent postrest potentiation. Pharmacology studies were performed in the ECTs to confirm the presence and functionality of pathways that modulate cardiac contractility in humans. Canonical responses were observed for compounds that act via the β-adrenergic/cAMP-mediated pathway, eg, isoproterenol and milrinone; the L-type calcium channel, eg, FPL64176 and nifedipine; and indirectly effect intracellular Ca2+ concentrations, eg, digoxin. Expected positive inotropic responses were observed for compounds that modulate proteins of the cardiac sarcomere, eg, omecamtiv mecarbil and levosimendan. ECTs generated in the Biowire II platform display adult-like properties and have canonical responses to cardiotherapeutic and cardiotoxic agents that affect contractility in humans via a variety of mechanisms. These data demonstrate that this human-based model can be used to assess the effects of novel compounds on contractility early in the drug discovery and development process.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/toxsci/kfz168

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 5 references

Cited by

See all 96

Metadata

Authors
Feric, N. T., Pallotta, I., Singh, R., Bogdanowicz, D. R., Gustilo, M. M., Chaudhary, K. W., Willette, R. N., Chendrimada, T. P., Xu, X., Graziano, M. P., & Aschar-Sobbi, R.
Venue
Toxicological Sciences
Published
2019-08-06
Volume
172
Issue
1
Pages
89-97
ISSN
  • 1096-0929 (ISSN-L)
  • 1096-6080
OpenAlex
W2965416064
Cited by
96
References
5
FWCI
3.58
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery. https://app.cochat.ai/papers/10.1093/toxsci/kfz168
The paper
Feric, N. T., Pallotta, I., Singh, R., Bogdanowicz, D. R., Gustilo, M. M., Chaudhary, K. W., Willette, R. N., Chendrimada, T. P., Xu, X., Graziano, M. P., & Aschar-Sobbi, R. (2019). Engineered Cardiac Tissues Generated in the Biowire II: A Platform for Human-Based Drug Discovery. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfz168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.